AMRN
Amarin Corporation PLCNASDAQHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$304.57M
P/E Ratio
—
EPS
$-1.80
Beta
0.82
52W High
$20.90
52W Low
$7.80
50-Day MA
$14.94
200-Day MA
$15.63
Dividend Yield
—
Profit Margin
-18.20%
Forward P/E
500.00
PEG Ratio
0.81
About Amarin Corporation PLC
Amarin Corporation plc, a pharmaceutical company, is engaged in the development and commercialization of therapies for the treatment of cardiovascular disease in the United States. The company is headquartered in Dublin, Ireland.
Fundamentals
| Revenue (TTM) | $213.65M |
| Gross Profit (TTM) | $120.87M |
| EBITDA | $-10.91M |
| Operating Margin | -4.59% |
| Return on Equity | -8.21% |
| Return on Assets | -1.29% |
| Revenue/Share (TTM) | $10.30 |
| Book Value | $22.07 |
| Price-to-Book | 0.67 |
| Price-to-Sales (TTM) | 1.43 |
| EV/Revenue | 0.0411 |
| EV/EBITDA | -5.80 |
| Quarterly Earnings Growth (YoY) | -94.20% |
| Quarterly Revenue Growth (YoY) | -21.00% |
| Shares Outstanding | $20.80M |
| Float | $367.03M |
| % Insiders | 1.96% |
| % Institutions | 22.56% |
Analyst Ratings
Consensus ($12.00 target)
1
Hold1
SellData last updated: 4/7/2026